Endocrine properties and mechanism of action of oral contraceptives.
D000818:Animals; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004970:Estrone / Q000494:pharmacology; D005040:Ethynodiol Diacetate / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007986:Luteinizing Hormone / Q000097:blood; D009639:Norethandrolone / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009641:Norethynodrel / Q000494:pharmacology; D009929:Organ Size; D006080:Ovarian Follicle / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D010906:Pituitary Hormone-Releasing Hormones; D011374:Progesterone / Q000378:metabolism; D011817:Rabbits; D011863:Radioimmunoassay; D051381:Rats; D014599:Uterus / Q000187:drug effects
D003276:Contraceptives, Oral; D010906:Pituitary Hormone-Releasing Hormones; D004970:Estrone; D011374:Progesterone; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009639:Norethandrolone; D009640:Norethindrone